Gilead Sciences Inc (GILD)
67.08
+1.15 +1.74%
NASDAQ
Dec 6, 16:59
Delayed 2m
USD
Gilead Sciences Revenue Estimates for Current Quarter
View 4,000+ financial data types
Browse...
View Full Chart
Revenue Estimates for Current Quarter Chart
Historical Revenue Estimates for Current Quarter Data
View and export this data going back to 1962.
Start your Free Trial
Export Data
Date Range:
| Data for this Date Range | |
|---|---|
| Dec. 4, 2019 | Upgrade |
| Nov. 19, 2019 | Upgrade |
| Nov. 12, 2019 | Upgrade |
| Nov. 7, 2019 | Upgrade |
| Oct. 25, 2019 | Upgrade |
| Oct. 24, 2019 | Upgrade |
| Oct. 22, 2019 | Upgrade |
| Oct. 21, 2019 | Upgrade |
| Oct. 16, 2019 | Upgrade |
| Oct. 14, 2019 | Upgrade |
| Oct. 11, 2019 | Upgrade |
| Oct. 10, 2019 | Upgrade |
| Oct. 4, 2019 | Upgrade |
| Oct. 3, 2019 | Upgrade |
| Sept. 30, 2019 | Upgrade |
| Aug. 13, 2019 | Upgrade |
| Aug. 6, 2019 | Upgrade |
| Aug. 5, 2019 | Upgrade |
| Aug. 1, 2019 | Upgrade |
| July 31, 2019 | Upgrade |
| July 29, 2019 | Upgrade |
| July 25, 2019 | Upgrade |
| July 24, 2019 | Upgrade |
| July 23, 2019 | Upgrade |
| July 22, 2019 | Upgrade |
| July 19, 2019 | Upgrade |
| July 16, 2019 | Upgrade |
| July 15, 2019 | Upgrade |
| July 14, 2019 | Upgrade |
| July 3, 2019 | Upgrade |
| July 1, 2019 | Upgrade |
| June 30, 2019 | Upgrade |
| May 21, 2019 | Upgrade |
| May 20, 2019 | Upgrade |
| May 7, 2019 | Upgrade |
| May 3, 2019 | Upgrade |
| April 30, 2019 | Upgrade |
| April 25, 2019 | Upgrade |
| April 23, 2019 | Upgrade |
| April 22, 2019 | Upgrade |
| April 18, 2019 | Upgrade |
| April 17, 2019 | Upgrade |
| April 12, 2019 | Upgrade |
| April 10, 2019 | Upgrade |
| April 3, 2019 | Upgrade |
| March 31, 2019 | Upgrade |
| March 14, 2019 | Upgrade |
| March 5, 2019 | Upgrade |
| Feb. 28, 2019 | Upgrade |
| Feb. 12, 2019 | Upgrade |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
View Revenue Estimates for Current Quarter for GILD
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
Start your free 7-Day Trial.
Start My Free Trial
No credit card required.
Already a subscriber? Sign in.
Revenue Estimates for Current Quarter Benchmarks
| Benchmarks | |
|---|---|
| Amgen Inc | Upgrade |
| Biogen Inc | Upgrade |
| Johnson & Johnson | Upgrade |
Revenue Estimates for Current Quarter Range, Past 5 Years
| Minimum | Upgrade | May 02 2018 |
| Maximum | Upgrade | Sep 30 2017 |
| Average | Upgrade |
News
Market Chatter: AstraZeneca, Gilead Sciences, Merck, AbbVie Slash Prices by 61% to Make it to China's New List
MT Newswires 11/29 09:49 ET
MT Newswires 11/29 09:49 ET
